Trials / Terminated
TerminatedNCT01888822
Antibiotic Prophylaxis in Laparoscopic Cholecystectomy
Ciprofloxacin, Ampicillin-sulbactam and Placebo Prophylaxis in Laparoscopic Cholecystectomy. A Randomized Controlled Study
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 138 (actual)
- Sponsor
- University of Roma La Sapienza · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The trial aims to assess the value of two-regimen antibiotic prophylaxis versus placebo in elective laparoscopic cholecystectomy.
Detailed description
All patients enrolled will be submitted to laparoscopic cholecystectomy. The primary aim of the trial will be to assess the role of prophylactic i.v. infusion of ampicillin-sulbactam, ciprofloxacin, and placebo to reduce the rate of surgical site infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ciprofloxacin | Prophylactic ciprofloxacin infusion before elective laparoscopic cholecystectomy |
| DRUG | Ampicillin-sulbactam | Prophylactic ampicillin-sulbactam infusion before elective laparoscopic cholecystectomy |
| DRUG | Placebo | Prophylactic placebo infusion before elective laparoscopic cholecystectomy |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2016-06-01
- Completion
- 2017-06-01
- First posted
- 2013-06-28
- Last updated
- 2020-03-25
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01888822. Inclusion in this directory is not an endorsement.